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Abstract 
 
Objective: Global tobacco control efforts in both prevention and treatment have 
advanced to levels never imagined 20 years ago. This review examines the 
relationship between mental illness and tobacco use, with particular focus on the 
role of psychiatrists in the treatment of tobacco dependence. Methods: The 
literature search utilised MEDLINE, Embase and PsychINFO databases using 
the terms psychiatry, psychiatrist, smoking cessation, tobacco use disorder and 
tobacco dependence treatment. A manual search of all references from relevant 
scientific articles obtained was also conducted. Finally, further material sourced 
included all major guidelines for smoking cessation or tobacco dependence 
treatment from the United States, United Kingdom, Canada, Australia and New 
Zealand.  Results: Psychiatry has ignored tobacco dependence and its treatment 
resulting in multiple missed opportunities in improving the health and well-being 
of smokers with mental illness. Improvement in the training and knowledge of 
psychiatrists and those in the mental health sector will be the most effective 
activity to rectify this situation. Conclusion: Psychiatry must recognise tobacco 
dependence as equally important as the primary mental illness and to treat 
accordingly. A significant change in the training of future psychiatrists, 
introducing or implementing smoke free mental health services, changes in the 
management of caring for the mentally ill, and the introduction of tobacco 
treatment specialists within the mental health system is needed if psychiatry is 
serious about confronting this problem. ASEAN Journal of Psychiatry, Vol. 16 
(1): January – June 2015: XX XX. 
Keywords: Tobacco Dependence Treatment, Smoking Cessation, Smoking, 
Addiction, Psychiatry 
 
 
Introduction 
 
Global tobacco control efforts in both 
prevention and treatment have advanced to 
levels never imagined 20 years ago [1]. 
Despite this, smoking is still the number one 
public health problem worldwide. Cigarette 
smoking is the preferred method of ingesting 
tobacco and causes the most harm. Cigarette 
smoke contains 7000 toxins and a substantial 
number of these are proven to be carcinogenic 
[2]. Smoking not only affects smokers 
individually but also those around them. 
Second-hand smoking (SHS), or 
environmental tobacco smoke (ETS), a class 
1A carcinogen, has been scientifically shown 
to be detrimental to health [3, 4]. An estimated 
six million lives are lost prematurely each year 
as a result of smoking and will increase by 
another four million as early as 2030 if the 
status quo [2]. 
 
In response to this threat to human health, the 
World Health Organization (WHO) 
established a treaty known as the Framework 
Convention for Tobacco Control (FCTC), 
which came into force in February 2005 [5]. 
There are now 176 nations that have ratified 
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this treaty, and the number is growing. The 
main aim was to assist member countries in 
their public health efforts against tobacco use, 
particularly in smoking. The treaty also 
provided new dimensions in legal health 
cooperation worldwide on tobacco control in 
response to various efforts by the tobacco 
industry to protect its interest using legal 
means [5,6]. Within the Asia Pacific region, 
Australia and New Zealand are at the forefront 
of this initiative, with the recent launch of 
plain packaging for all cigarette sales in 
Australia [7],  and New Zealand’s declaration 
to be a smoke free nation by 2025 [8]. 
Through its commitment to be smoke free by 
2025, New Zealand will use all initiatives 
available to reach this goal. Both of these 
initiatives are being closely observed by other 
FCTC member countries including those in 
Southeast Asia. 
 
Advances in public health measures have 
brought about reductions in the prevalence of 
tobacco use and dependence. The effect of this 
has been an increasingly ‘hard to treat’ group 
of addicted patients at a clinical level [9]. 
Psychiatrists could be argued to be the ideal 
practitioners to treat tobacco dependence when 
there is greater clinical complexity due to their 
training in the interaction between physical, 
psychological and pharmacological factors 
impacting on addiction and tobacco use 
together with social contextual issues [4,10]. 
They are also skilled in many forms of 
psychological interventions such as cognitive-
behavioural therapy, motivational interviewing 
and relapse prevention along with prescribing 
pharmaceuticals [4]. Sellman [11] had 
previously called for psychiatry to “embrace 
nicotine dependence as the leading mental 
disorder of our age” noting that advancements 
in both the science of nicotine addiction and 
ways to manage it are rapidly advancing. 
 
This review examines the relationship between 
mental illness and tobacco use and the role of 
psychiatrists in the tobacco dependence 
treatment. Finally, possible solutions are 
offered in order to advance the role of 
psychiatrists in the treatment of tobacco 
dependence.  
 
Methods 
 
A  literature  review   was   conducted  in  July 
2012 using the MEDLINE (From 1946 till 
current), EMBASE and PsycINFO online 
database. Search terms included psychiatry, 
psychiatrist, smoking cessation, tobacco use 
disorder and tobacco dependence treatment. 
Searches were limited to humans and English 
publications. Articles that were related to 
surveys on psychiatrists and their involvement 
with smoking cessation or tobacco control 
were kept for in-depth review. A second 
search through the references of these 
publications was conducted to identify 
publications that were missed using the 
databases mentioned.  Publications were 
excluded if they did not include information 
on these topics. 
 
The initial literature search identified 515 
journal articles. A single author (A.S) read the 
abstracts of these articles. A total of 486 
articles were excluded as they were not 
pertaining to psychiatrists and smoking 
cessation resulting in 29 articles that were 
retrieved for in-depth review. A further 18 
were excluded as they were not surveys, 
therefore 11 were kept. Further search through 
these articles recovered two articles that were 
not included in the first search for a total of 13 
published articles surveying psychiatrists and 
their role in smoking cessation. A manual 
search of all references from relevant scientific 
articles obtained was also conducted. Finally, 
further material sourced included all major 
guidelines for smoking cessation or tobacco 
dependence treatment from the United States, 
United Kingdom, Canada, Australia and New 
Zealand. 
 
Mental Illness and Tobacco Use  
 
Individuals with mental illness are more likely 
to be current smokers compared to the general 
public as a whole.  On average, two to three 
times as many people with mental illness 
smoke [12-14]. Conditions such as 
schizophrenia are associated with smoking 
prevalence of up to 85% [13, 15]. Those with 
schizophrenia also smoke more (defined as 
smoking more than 25 cigarettes per day) [16, 
17], have higher dependence or severity scores 
compared to the general public [18], and have 
been found to be more “efficient smokers” 
[19], absorbing more nicotine with each puff. 
People with mental illness constitute 16% of 
the New Zealand population [20] but smoke 
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33% of cigarettes consumed [21]. Similarly, in 
the United States where 25% of the population 
has mental illness [11], Lasser [17] found that 
nearly 44% of all cigarettes sold were 
consumed by those with mental illness, with 
Grant et al. [23], reporting 57.6%.  
 
Although smoking is highly prevalent and the 
consequences debilitating, those with mental 
illness and nicotine dependence are generally 
neglected in psychiatry [24, 25]. It is common 
for them to be excluded from smoking 
cessation trials or not included in quit smoking 
initiatives altogether [26, 27]. Some 
professionals have referred to this group as the 
“underserved” population [28], and together 
with other groups, such as the low-
socioeconomic population, often have high 
prevalence and more difficulties in quitting 
smoking. 
 
The connection between mental illness and 
tobacco use is still not fully understood [13, 
16]. A complex interplay between biological, 
psychological and social factors has been 
suggested [13], which is likely to vary 
according to specific mental illness under 
question.  
 
In schizophrenia for example, the involvement 
of the alpha-7 nicotinic receptor may be faulty 
[13]. Geneticists have found a link between 
this receptor and chromosome 15 which is 
believed to be linked with nicotine addiction 
[29]. The α-7 nicotinic receptor is involved 
with a physiological response to repeated 
auditory stimuli and also cognition in 
particular at the visuo-spatial working memory 
[13]. Abnormalities in both areas are linked to 
increased smoking as nicotine has been found 
to assist in minimising the side-effects from 
these abnormalities [31]. Psychosocial factors 
such as poverty, unemployment, lower levels 
of education and difficulties in accessing 
health services, often found in those with 
schizophrenia, are also important [13]. On the 
other hand, in anxiety disorders for example, 
especially post-traumatic stress disorder 
(PTSD), the hypothalamic-pituitary-adrenal 
(HPA) axis may be at fault. Impairment in the 
HPA axis may lead to the development of 
nicotine tolerance [13]. Alterations in this 
system can cause cortisol 
interference/involvement which increases the 
risk of smoking in those with PTSD by 
enhancing both tolerance and sensitization to 
various effects of nicotine. Other factors that 
may lead to increase smoking within this 
group are psychological factors such as 
“anxiety sensitivity” and negative affect which 
can act as cues to initiation or continued 
smoking [13]. A low threshold for distressing 
situations and deficits in cognitive-emotional 
processing may also play a role in the 
relationship between smoking and anxiety 
disorders.  
 
Unlike schizophrenia and anxiety disorders 
where the association appears to be 
unidirectional, the association for depression is 
thought to be bidirectional [13, 32].  Some 
studies report a moderating role of 
dopaminergic genes and depressive symptoms 
in determining both adolescent and adult 
smoking practices [13]. Others, however, 
suggest psychosocial stresses associated with 
depression make the individual highly 
sensitive to the reinforcing effects of smoking, 
and/or increase the vulnerability of the 
individual to social smoking influences [13]. 
The relationship between biological and 
psychosocial factors in determining smoking 
and mental illness is clearly a complex one. 
 
Psychiatry and Tobacco Use 
 
Tobacco use and its treatment have been 
underemphasised in psychiatry. One example 
is the establishment of smoke-free inpatient 
services. Despite many countries having 
environmental or similar laws to prevent 
smoking in closed buildings such as hospitals 
[1], not all inpatient psychiatric facilities are 
smoke-free [30].  In Christchurch, New 
Zealand, it has taken half a decade longer for 
all mental health services to be smoke free, 
achieving this in 2010 [31] compared to all 
public hospitals in New Zealand which have 
been smoke free since December 2004 [32]. 
 
Benefits of Tobacco Dependence Treatment 
 
The benefits in treating tobacco dependence 
are significant for those with or without mental 
illness. Treating tobacco dependence improves 
the lives of both the smoker and those around 
them. Smoking causes many health problems 
such as lung and cardiovascular diseases but 
these conditions on quitting are reversible to a 
degree [33]. Studies have found that those who 
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quit experience early benefits of improved 
respiratory and cardiovascular functions [34]. 
More chronic conditions, such as cancer, are 
lowered as early as five years post abstinence 
[35]. Quitting smoking not only reduces the 
risk for medical health co-morbidities but has 
also been found to reduce the risk of 
developing substance abuse [27]. It may also 
increase the likelihood of stopping other 
existing substance abuse problems [27]. 
 
Tobacco use has also been shown to affect 
psychiatric treatments. Antipsychotic 
medication for schizophrenia, such as 
olanzapine and clozapine as well as certain 
antidepressants such as fluvoxemine are 
broken down by the cytochrome P450 enzyme 
system in the liver [36, 37].These enzymes are 
affected by the hydrocarbons in cigarette 
smoke. Smoking increases the breakdown of 
these medications leading to reduced serum 
drug concentration. Those requiring these 
treatments will therefore need higher dosing 
which is not only potentially dangerous and 
can lead to other health complications like 
metabolic syndrome but is also expensive to 
the health system [36]. Similarly, on quitting 
smoking, these same levels may be elevated 
and will need to be carefully reassessed. 
 
Treating tobacco dependence unfortunately is 
not generally undertaken as part of normal 
clinical practice by psychiatrists despite being 
one of the most cost effective interventions 
available at a population level [37]. Tønnesen 
[38], after reviewing several meta-analyses, 
found that treating those with tobacco 
dependence was much more cost effective 
compared to other public health interventions 
such as mammograms or providing treatments 
for elevated serum cholesterol levels. He 
reported the cost of adjusted quality of life 
years (QALY) to be between $550-2200 
(adjusted USD). Cromwell et al. [39] found 
the cost of adjusted QALY to be between 
US$1108-4542 and also the more intensive the 
intervention the more cost effective it was. It is 
now recognised that current efforts to reduce 
the national prevalence further are limited by 
those with severe nicotine addiction who are 
generally more difficult to treat and less likely 
to respond to available treatments [9]. Many 
individuals with mental illness who smoke fit 
this description, and their widespread 
treatment by psychiatrists and other mental 
health clinicians are likely to assist at a 
population level in reducing national smoking 
prevalence rates further. 
 
Barriers and Solutions 
 
There have been a number of barriers 
identified as to why psychiatrists are hesitant 
to conduct tobacco dependence treatment. 
Among these barriers is the failure to inculcate 
interest to conduct smoking cessation among 
psychiatrists at the outset of their training, the 
lack of interested supporting staff, and/or 
unavailability of appropriate infrastructure.  
 
Prochaska [40] commented that one of the 
main reasons that tobacco control has been 
delayed this long in psychiatry can be 
attributed to the “self-medication hypothesis”. 
This hypothesis states that individuals with 
mental illness “self-medicate” with tobacco 
smoking to reduce or remove distressing 
symptoms that they may have experienced 
from their mental illness. For example, in 
schizophrenia, abnormalities in α7-nicotinic 
receptor have been linked to the presence of 
auditory hallucinations through the P50 gating 
response [13]. Tobacco smoking affects the 
P50 gating response and therefore may assist 
by reducing these symptoms. Similarly for 
depression, patients may smoke as a result of 
the effect of tobacco smoking on monoamine 
oxidase inhibitors responsible for the 
breakdown of the neurotransmitters dopamine 
and serotonin [36]. Smoking, therefore, may 
elevate mood by acting like antidepressants. 
Side-effects such as akathisia, caused by 
conventional antipsychotic use, in the 
treatment of schizophrenia, are also thought to 
be reduced by tobacco smoking [41]. These 
findings, however, were not missed by the 
tobacco industry. In another study Prochaska, 
Hall and Bero [15] found that the tobacco 
industry had acted upon this knowledge by 
slowing down efforts to treat smokers with 
schizophrenia through promoting self-
medication as one of the strategies used to 
market cigarettes to patients with 
schizophrenia. 
 
Another major barrier in tobacco dependence 
treatment in psychiatry is the delay in 
implementing smoke free services in mental 
health. Questions are still being asked if this 
move is necessary in certain parts of the world 
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[30]. At times, it is the service provider 
themselves that are not keen for the 
implementation of smoke-free services [42-
44]. Among the reasons cited are that patients 
will relapse if asked to quit or will react 
aggressively, they are not motivated to quit as 
it is not their priority and smoking is used both 
as a ‘reward’ for positive behaviour and a 
‘tool’ for engagement between mental health 
staff and patients [40, 45]. 
 
The high rate of smoking amongst mental 
health staff is also a barrier for treatment 
provision. Many studies have shown that staff 
working in mental health services often report 
higher smoking prevalence compared to their 
peers [44, 46]. Those who smoke have been 
shown to be least likely to assist smokers to 
quit or acknowledge that smoking is a problem 
for the patient in their care [46]. A study by 
Morris, Waxmonsky, May, & Giese [47] using 
a qualitative approach found that patients 
reported difficulty in attempting to quit when 
those treating them also smoked. 
 
A series analysis of publications which 
primarily surveyed psychiatrists on various 
aspects of tobacco dependence treatment, 
revealed a number of psychiatrist specific 
barriers. Lubman, Jorm, & Morgan [48] 
surveyed 2000 general practitioners and 1710 
psychiatrists on their belief regarding 
appropriate interventions for mental disorder 
in youth using a clinical vignette and found 
that compared to general practitioners, 
psychiatrists in the study endorsed less belief 
in the helpfulness of reducing smoking for 
young people with either psychosis or 
depression. However, the study had a low 
response rate (24% for general practitioners 
and 35% for psychiatrists). Another survey 
[49] of 80 psychiatrists working in a 
community mental health centre found that 
20% did not even consider enquiring about 
their patients’ smoking status. Ratschen, et al. 
[44], found that among workers in an inpatient 
unit in the United Kingdom, where the 
majority were psychiatrists (junior and 
consultants), there was a lack of knowledge in 
tobacco dependence, its treatment and 
relationship with mental illness. This lack of 
knowledge could be based on misconceptions 
that psychiatrists might not believe their 
efforts would lead to any success [49], or that 
smoking cessation was not as important as 
treating the primary mental illness [49, 50].  
 
A survey of 105 trainee psychiatrists in all 
years of training in the United States found 
more than three quarters reported their ability 
to assist smokers to be fair to poor [51].  They 
also reported no, or inadequate, training in 
tobacco dependence treatment in both medical 
undergraduate and postgraduate training. On a 
scale of 1 to 5 for confidence, the average 
rating was 3. In this sample, a third reported 
either being current or ex-smokers. In another 
survey of 114 psychiatry residency training 
directors [52], only half reported their centres 
provided training and that the median time 
spent was an hour. A follow-up post 
implementation training survey indicated an 
increase in both knowledge and skill and a 
subsequent increase in confidence in treating 
nicotine dependent people 
[53].Implementation was found to be of 
minimal cost and all respondents would 
recommend the training to their peers [53]. A 
recently conducted literature review on 
MEDLINE up to 31 July 2013 did not reveal 
any new studies on training of tobacco control 
and dependence treatment in postgraduate 
psychiatry training, despite previous concerns 
that trainees had a lack of knowledge and 
skills in assisting smokers to quit.  A survey of 
74 psychiatrists, chairs of US academic 
psychiatry, found that although just under two 
thirds agreed that stopping cigarette smoking 
was “very” important and more than two thirds 
supported tobacco dependence treatment 
programs, less than half of them had such 
programs in their respective institutions [54]. 
Continuous medical education (CME) on 
tobacco dependence and mental illness was 
also found to be lacking and often reported as 
one of the main reasons for the lack of 
knowledge and treatment [44,49,55,56]. 
 
Most treatment guidelines recommend the 5 
A’s (ask, advise, assess, assist, arrange), as 
their main approach to managing tobacco 
dependence [57-59]. New Zealand, however, 
uses a modified ABC (ask, brief advice, 
cessation support) in its guidelines [60]. A 
consequence of the lack of training was the 
unfamiliarity with guidelines, treatment and 
services available to refer to. Using the 
National Ambulatory Care Survey which was 
conducted in the 1990s, Himelhoch & Daumit 
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[61] found that only 12.4% of patients with 
mental illness were offered tobacco 
dependence treatment. None were given a 
diagnosis of nicotine addiction and none were 
prescribed nicotine replacement therapy 
(NRT) or any other pharmacological 
intervention. Three other studies also found 
similar findings in prescribing practices of 
NRT by psychiatrists (9.7% [62], 10% [49] 
and 37% [56]). Another study by Price et al. 
[55], involving child and adolescent 
psychiatrists, found that NRT was not the 
standard care in their practice. An audit survey 
on diagnosis of nicotine dependence for three 
years in a youth speciality service where 
psychiatrists practiced revealed only a 3.6% 
written diagnosis in the first year of audit. This 
number jumped to 26.3% two years later, 
understood most likely to be the result of 
discussion regarding the low number and 
interest in the field [63].  
 
Nicotine dependence has already been 
recognised as a medical condition in both the 
International Classification of Disease (ICD) 
and the Diagnostic Statistical Manual of 
Mental Illness (DSM) [64,65]. However, due 
to the lack of awareness as highlighted, the 
condition is seldom documented [63, 66]. 
Without diagnosis documentation, the 
importance in treating the tobacco dependence 
may be lost [62]. Opportunity to provide 
treatment and the possibility for 
reimbursement was reduced. It is of interest to 
note that other studies [46,50,61,67], reported 
that surveys on other specialities such as 
primary care and even medical colleagues 
reveal they were detecting and treating 
patients with mental illness who want to quit 
more often than psychiatrists. 
 
Apart from providing direct treatment, referral 
is also one of the strategies to assist smokers to 
quit [57,60]. Psychiatrists like other 
physicians, have time constraints and one 
method of assisting patients to quit smoking is 
to refer them to tobacco dependence treatment 
services within the community they are 
working in. However, Steinberg, et al.[50] 
who surveyed 5726 physicians in the New 
Jersey area found that psychiatrists were least 
likely to be familiar with existing services in 
that area compared to their peers, such as 
primary care physicians, respiratory physicians 
or even cardiologists. Williams, et al. [56], 
also found that psychiatrists in the study were 
not familiar with services available to them 
and therefore referred only a quarter of the 
time and 10% of these were referrals to quit-
line services.  
 
The Way Forward 
 
More training has been shown to improve 
detection, action to assist and also referral or 
treatment provision in both trainees and 
psychiatrists. A study by Prochaska et al. [53], 
on 55 psychiatry residents attending a four 
hour training session noticed an increase in 
knowledge, improved attitude towards tobacco 
dependence training in psychiatry and 
confidence for treatment provision. 
Confidence was sustained for three months in 
follow-up data (p<0.005). Williams, et al. [56], 
also found in a two day training session for 41 
mental health service providers, where 51% of 
them were psychiatrists, that participants 
scored better on post test scores from 47% to 
91% after day two. Participants were also very 
positive on feedback evaluation for this study. 
Apart from the general acceptance of such 
training for psychiatrists, Prochaska et al. [53], 
also found that training was cheap at US$139 
per participant. Follow-up training can be 
maintained through continuing medical 
education (CME) sessions. Easton et al. [67], 
found that physicians (including psychiatrists) 
who completed >16 CME monthly hours were 
more likely to frequently counsel compared to 
those who received less. Price, et al. [55], in a 
study looking at child and adolescent 
psychiatrists, found that the more confident 
and prepared the respondents were, the less 
barriers were reported. Steinberg et al. [50],  
also reported that although initially referrals 
were low amongst psychiatrists in the study, 
once familiar with available services their 
referral rate was similar to others. Training 
definitely increases awareness, diagnosis 
documentation and subsequently treatment 
provision and introducing tobacco treatment 
specialisation (TTS) amongst psychiatrists 
may further assist the agenda of tobacco 
control within psychiatry [68].  
 
Morris et al. [47], found from interviews that 
those with mental illness are already facing 
many barriers to access treatment. It would 
therefore be helpful if they could get access to 
tobacco control services from those trained in 
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both mental illness and tobacco dependence to 
ensure that their needs are adequately met.  
Prochaska et al. [52], noted that one reason for 
the lack of implementation of tobacco 
dependence treatment in all residency training 
centres was the lack of expertise on smoking 
cessation among qualified psychiatrists. 
Having a TTS program within each mental 
health services, or shared between a number of 
services, might improve treatment in a number 
of ways. A dedicated TTS would be able to 
“jump start” training and push for more 
awareness, and also be a source of information 
and support to other practitioners interested in 
tobacco dependence treatment [68-70]. 
Further, a TTS within a mental health service 
would be an excellent referral person to assist 
with more difficult cases within the mental 
health system [68].  
 
Tobacco treatment specialist specialisation in 
mental health settings is one method of 
increasing awareness of tobacco control 
among practitioners [68]. As highlighted in the 
study by Prochaska et al. [52], one reason why 
residency training did not implement such 
training is the lack of experts. Current 
available treatments are medications and 
interventions familiar to psychiatrists such as 
nortriptyline and cognitive behavioural 
therapy for example, and the side effects that 
have been reported such as mood disturbances 
are also under the purview of psychiatrists. 
Having an expert in the field has an advantage 
in providing a supportive environment where 
other colleagues can exchange information and 
learn [68-70]. At present, those that do receive 
slightly more attention in tobacco dependence 
among mental illness patients are those with 
co-morbid medical illnesses [46, 61]. 
Although reassuring to an extent, these 
findings also indicate that detection is only 
made for the most complex of cases in 
psychiatry. As many of the complex mental 
health patients have both psychiatric and 
addictive disorders, specialists of all 
disciplines are referring more to TTS [70, 71]. 
  
The increasing establishment of smoke free 
mental health units will also make a difference 
in tobacco dependence treatment in psychiatry. 
However, this will also need to be 
complemented with a change in the current 
culture of psychiatry with respect to tobacco 
dependence [44, 66]. Inpatient admissions into 
a smoke free unit may encourage quitting.45 
Contrary to popular belief, there is no added 
burden to manpower in terms of patient 
aggression through this action [45]. Parker, 
McNeill, & Ratschen [72], carried out a pilot 
study in four adult psychiatric wards and 
found 31% of patients attending tobacco 
dependence treatment services attempted a 
quit attempt, of which half were successful. 
This may not be feasible for some centres 
considering this study employed a specifically 
designed pathway to attain services. 
Nevertheless, it indicated that patients can and 
want to quit smoking [73]. In another study, 
Lawn & Pols [45] reported that mental health 
staff increased their quit attempts when smoke 
free inpatient units were established. Staff who 
did not smoke was more likely to be receptive 
of tobacco dependence treatment, and were 
more likely to encourage assistance and 
referrals [74]. Furthermore, staff who did not 
smoke could also become role models to 
patients and other staff [47, 75]. Previous 
studies had reported that a change in status, 
namely from smoking to smoke free, was not 
always associated with a change of culture 
when no clear strategies and appropriate 
resources were in place [72]. The culture of 
engaging with patients through smoking and 
smoking breaks needs to be addressed by both 
patient and mental health practitioners [40-42].  
Morris et al.[47], related a patient describing 
his difficulties as “give me something to 
occupy my time. There is nothing to 
do…except smoke, sleep and shower”. 
Experiences similar to this will need serious 
consideration if and when all units become 
smoke free. Another change needed will be the 
management of smokers within the unit [62, 
66]. The recognition of smoking and the need 
to address the above suggestions would need 
management changes in terms of ward work. 
Regular documentation of diagnosis, a system 
to remind psychiatrists and staff to follow-up 
on patients and familiarity with treatment both 
psychological and pharmacological are among 
some of the suggestions made by researchers 
in this area [42, 62, 66]. Patients themselves 
have also reported the use of group or peer 
support to be useful for them [47]. Studies 
have also shown that group therapy is equally 
effective in assisting to quit smoking [76, 77] 
and could easily be initiated in an inpatient or 
outpatient mental health setting.  
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Reimbursement for treatment has also been 
reported in several studies [49, 56, 62] as 
barriers to implement services. 
Reimbursement however needed 
accountability of services [77] and that is 
where the TTS could play a role [68, 71, 78]. 
Reimbursement has been shown to increase 
usage [79]. Although no increase in the 
proportion of quit attempts were found, it was 
suggested that changes may be too small at the 
national level to have a beneficial public 
health impact. However, unlike West et al., 
[79]; Thornley, Jackson, McRobbie, Sinclair, 
& Smith80 found that in New Zealand not all 
levels of society showed increased use in 
pharmacological treatments (in this case, 
NRT) despite being subsidized. In this study, 
Māori and Pacific people were not shown to 
acquire treatment compared to those of 
European ethnicity. A Cochrane Review 
involving eleven trials had, on the other hand, 
reported favourable impact for smokers to quit 
on full subsidization but not for health 
providers. Smokers who were fully assisted 
were nearly three times likely to be abstinent 
for six months or more (RR 2.45, CI 1.17-
5.12) [81]. Smokers were also more likely to 
use behavioural interventions with full aid (RR 
1.77, CI 1.19-2.65) [81]. These findings are 
useful as smokers with mental illness were 
usually the more challenging patients and 
normally require this additional support. In 
addition, current evidence indicates greater 
success with a combination of both 
pharmacological and psychological 
interventions [57, 59, 60]. 
 
Among the major challenges faced by 
psychiatrists is the need to fully recognise 
tobacco dependence as equally important as 
the mental illness conditions they treat 
regularly. This will involve an overhaul in 
both medical school and residency training in 
psychiatry. Management changes may also be 
required in order for psychiatrists to be serious 
in their responsibility to their patients who are 
addicted to tobacco smoking. 
 
Further implementation of smoke free mental 
health facilities is also needed. The longer 
these facilities are allowing psychiatric 
patients to smoke, the more harm is caused to 
the patients and mental health staff working in 
these facilities.The science of tobacco 
dependence and its treatment is rapidly 
advancing from the realms of genetics, 
imaging and also pharmacology. Psychiatrists 
need to be familiar with these changes in order 
to provide the best level of care [82]. Newer 
treatments, such as varenicline, can cause 
mood changes and has a warning for suicide 
[83]. Psychiatrists need to be aware of this and 
other potential interaction between treatment 
for tobacco dependence and existing 
treatments available. Newer devices such as 
electronic cigarettes, which are not yet well 
understood in terms of benefits and potential 
risk, should also be investigated by 
psychiatrists as treatment options for their 
patients [84, 85]. 
 
Conclusions 
 
Psychiatrists have ignored tobacco dependence 
and its treatment for too long, resulting in 
multiple missed opportunities in improving the 
health and well-being of smokers with mental 
illness. Improvement in the training and 
knowledge of psychiatrists and those in the 
mental health sector will be the most effective 
activity to rectify this situation. More research 
is needed in both the pre-clinical sciences and 
clinical care in order to improve existing 
services in psychiatry and the provision of 
tobacco dependence treatment. 
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